[Effectiveness, safety and adherence to therapy with Elicea Q-Tab in real clinical practice].
Igor OleichikP A BaranovPublished in: Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova (2023)
The study showed that escitalopram in the form of oral tablets dispersible in the oral cavity (Elicea Q-Tab) is an efficient and safe treatment for depressive and anxiety disorders in real-world clinical settings. Patients and physicians have evaluated the drug positively and it can be considered as an effective agent in psychiatric practice.
Keyphrases
- primary care
- clinical practice
- end stage renal disease
- ejection fraction
- newly diagnosed
- randomized controlled trial
- healthcare
- mental health
- prognostic factors
- bipolar disorder
- major depressive disorder
- peritoneal dialysis
- emergency department
- metabolic syndrome
- patient reported outcomes
- quality improvement
- replacement therapy
- cell therapy